RxDoctor Payments Data

Andrew Hein, DO

Family Medicine · Wauchula, FLNPI 1609004902

Payments from drug & device makers

$1,004in general payments, 2019–2025

Across 48 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$196
  • Abbott$146
  • Dexcom, Inc.$123
  • AstraZeneca$70
  • Lilly USA, LLC$69
  • Novartis$63
  • plus $338 from 9 others

What the payments were for

  • Food & beverage$1,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,004 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$183
Medicare patients
15
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol132$188,581
EliquisApixaban90$116,870
JardianceEmpagliflozin77$114,245
JanuviaSitagliptin Phosphate66$83,114
Tresiba Flextouch U-100Insulin Degludec77$75,133
TrulicityDulaglutide38$56,916
EntrestoSacubitril/Valsartan33$40,940
Spiriva HandihalerTiotropium Bromide29$39,684
OzempicSemaglutide28$39,092
SymbicortBudesonide/Formoterol Fumarate60$32,080
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$31,610
XareltoRivaroxaban19$29,366
MyrbetriqMirabegron32$21,699
InvokanaCanagliflozin15$20,978
Lantus SolostarInsulin Glargine,hum.Rec.Anlog107$15,327

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$70$220,662192 claims
PfizerEliquis$49$116,87090 claims
MerckJanuvia$36$83,11466 claims
Lilly USA, LLCTrulicity$69$56,91638 claims
NovartisEntresto$63$40,94033 claims
Novo NordiskOzempic$49$39,09228 claims
GSKTrelegy Ellipta$43$31,61019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Wauchula

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →